HK IPO pricing immune to A-share jitters

The IPOs of Legend Holdings and Red Star Macalline last week defied plummeting A-shares to price at the top, as books opened for Universal Medical's HK float.

HK IPO pricing immune to A-share jitters

A near-12% drop in China’s A-share markets last week has not affected Hong Kong’s IPO market, with a number of issuers pricing shares at the top of the range, indicating there is still demand for primary offerings.

Despite plunging markets last week, Red Star Macalline Group, backed by private equity firm Warburg Pincus, managed to price its shares at the top of its indicative range and raise $931 million in its IPO.

To continue reading, please login or register for free

Print Edition

FinanceAsia Print Edition


  • 2nd Compliance Summit Southeast Asia

    17 August 2017  |  Singapore
    The 2017 Compliance Summit Southeast Asia will take an in-depth look at the key compliance considerations today with a focus on regulation and new ...